Pfizer (PFE) Tops Q2 EPS by 11c, Updates FY Guidance

Pfizer (NYSE: PFE) reported Q2 EPS of $1.07, $0.11 better than the analyst estimate of $0.96. Revenue for the quarter came in at $19 billion versus the consensus estimate of $18.45 billion.

GUIDANCE:

Pfizer sees FY2021 EPS of $3.95-$4.05, versus the consensus of $3.70. Pfizer sees FY2021 revenue of $78-80 billion, versus the consensus of $72.78 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Champions Oncology (CSBR) Tops Q1 EPS by 6c
• Navan, Inc. (NAVN) Tops Q2 EPS by 1c, Offers Guidance